The expression rate of EGFR in NPC patients exceeds 90%, and patients with high expression of EGFR were more likely to experience locoregional recurrence and distant metastasis (Sun et al., 2014). The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.